LEUKOLABS

350 million patients globally have rare genetic diseases, including 3.5 million in the UK. Leukodystrophies are devastating rare diseases with limited treatment and research on leukodystrophy is under-represented in the UK. A more collaborative and united approach in leukodystrophy research will bring together our national experts and allow rapid and efficient progress towards therapeutic interventions. O U R G O A L S: To unite researchers and clinicians working on leukodystrophies, promote collaborative projects and develop therapies.